Indications for axillary dissection in T1 breast cancer

Annals of Surgical Oncology

Volumn 5, Issue 1, 1998, Pages 4-8

  Mustafa, Isha A ^a   Bland, Kirby I ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Breast cancer; Lymphadenectomy; Metastases

Indexed keywords

ALGORITHM; ARTICLE; BREAST CANCER; CANCER GRADING; DATA ANALYSIS; DISSECTION; INCIDENCE; LYMPHADENECTOMY; METASTASIS; PROBABILITY; RISK FACTOR; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; TREATMENT OUTCOME;

EID: 0031847860     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303756     Document Type: Article

References (15)

1. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994;73:664-7.
2. Mustafa IA, Cole B, Wanebo HJ, et al. The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 1997; 132:384-91.
3. Fisher B, Redmond C, Fisher ER. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without irradiation. New Engl J Med 1985;32:674-81.
4. Early Breast Cancer Trialists' Cooperative Group. Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 1995; 333:1444-55.
5. White RE, Vezeridis MP, Konstadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: Influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996;183:575-82.
6. Cabanes PA, Salamon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-8.
7. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-44.
8. Halverson KJ, Taylor ME, Perez CA, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994;17:461-6.
9. Baxter N, McCready D, Chapman JA, et al. Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer. Ann Surg Oncol 1996;3:235-40.
10. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;218:338-49.
11. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: A review. Cancer 1995;76:1491-1512.
12. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhart M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histological nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
13. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.
14. Danforth DN, Findlay PA, McDonald HP, et al. Complete axillary node dissection for stages I and II carcinoma of the breast. J Clin Oncol 1986;4:655-62.
15. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 1996;183:185-9.